Showing 121 - 128 results of 128 for search '(( significant decrease decrease ) OR ( significantly ((worse decrease) OR (a decrease)) ))~', query time: 0.48s Refine Results
  1. 121

    ZNF503-AS2 had predictive value for chemotherapy and immunotherapy in glioma. by Yibo Wu (788885)

    Published 2024
    “…(J) Patients with high TIDE scores had a worse prognosis. (K) The low ZNF503-AS2 expression group may have a better response to immunotherapy. …”
  2. 122

    Table 1_Executive functions in post-traumatic stress disorder: their relation to PTSD severity and daily functioning.pdf by Nehal Safi (22633127)

    Published 2025
    “…Correlations were found between BRIEF-A and VAP-S 2: more collisions and lower inhibition in VAP-S 2 were correlated with worse BRIEF-A scores. …”
  3. 123

    Image 2_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”
  4. 124

    Image 1_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”
  5. 125

    Image 4_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”
  6. 126

    Image 6_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”
  7. 127

    Image 3_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”
  8. 128

    Image 5_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The dynamic mortality risk rate revealed a double peak in the high-risk patients (12 and 48 months) and a single peak in the low–risk patients (24 months) and middle-risk patients (12 months), which gradually decreased over time.…”